WO1997028840A1 - Dispositif d'expansion de tissus prostatiques - Google Patents
Dispositif d'expansion de tissus prostatiques Download PDFInfo
- Publication number
- WO1997028840A1 WO1997028840A1 PCT/US1996/002500 US9602500W WO9728840A1 WO 1997028840 A1 WO1997028840 A1 WO 1997028840A1 US 9602500 W US9602500 W US 9602500W WO 9728840 A1 WO9728840 A1 WO 9728840A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- balloon
- catheter
- tissue
- expander
- prostatic
- Prior art date
Links
- 238000000034 method Methods 0.000 claims abstract description 32
- 210000002700 urine Anatomy 0.000 claims abstract description 29
- 210000001519 tissue Anatomy 0.000 claims description 87
- 210000003708 urethra Anatomy 0.000 claims description 45
- 239000012530 fluid Substances 0.000 claims description 30
- 210000002307 prostate Anatomy 0.000 claims description 29
- 239000000463 material Substances 0.000 claims description 16
- 239000000017 hydrogel Substances 0.000 claims description 11
- 239000003242 anti bacterial agent Substances 0.000 claims description 6
- 229940088710 antibiotic agent Drugs 0.000 claims description 6
- -1 hydrophilics Substances 0.000 claims description 6
- 238000003780 insertion Methods 0.000 claims description 6
- 230000037431 insertion Effects 0.000 claims description 6
- 208000014674 injury Diseases 0.000 claims description 4
- 230000008733 trauma Effects 0.000 claims description 4
- 238000004891 communication Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 claims description 2
- 210000003899 penis Anatomy 0.000 claims description 2
- 235000008733 Citrus aurantifolia Nutrition 0.000 claims 1
- 235000011941 Tilia x europaea Nutrition 0.000 claims 1
- 239000004571 lime Substances 0.000 claims 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 abstract description 6
- 208000004403 Prostatic Hyperplasia Diseases 0.000 abstract description 6
- 230000010339 dilation Effects 0.000 description 24
- 229920001296 polysiloxane Polymers 0.000 description 15
- 229920001971 elastomer Polymers 0.000 description 14
- 239000000806 elastomer Substances 0.000 description 14
- 230000001105 regulatory effect Effects 0.000 description 14
- 229920001169 thermoplastic Polymers 0.000 description 11
- 239000004416 thermosoftening plastic Substances 0.000 description 11
- 210000005070 sphincter Anatomy 0.000 description 10
- 229910052751 metal Inorganic materials 0.000 description 7
- 239000002184 metal Substances 0.000 description 7
- 229920002635 polyurethane Polymers 0.000 description 7
- 239000004814 polyurethane Substances 0.000 description 7
- 230000003115 biocidal effect Effects 0.000 description 6
- 229920000126 latex Polymers 0.000 description 6
- 239000004816 latex Substances 0.000 description 6
- 230000002787 reinforcement Effects 0.000 description 6
- 230000003466 anti-cipated effect Effects 0.000 description 5
- 230000007774 longterm Effects 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 230000005660 hydrophilic surface Effects 0.000 description 4
- 235000015110 jellies Nutrition 0.000 description 4
- 239000008274 jelly Substances 0.000 description 4
- 230000002485 urinary effect Effects 0.000 description 4
- 230000004888 barrier function Effects 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000000560 biocompatible material Substances 0.000 description 3
- 230000006835 compression Effects 0.000 description 3
- 238000007906 compression Methods 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 230000001050 lubricating effect Effects 0.000 description 3
- 210000000664 rectum Anatomy 0.000 description 3
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- 230000003444 anaesthetic effect Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000007334 copolymerization reaction Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- SUPCQIBBMFXVTL-UHFFFAOYSA-N ethyl 2-methylprop-2-enoate Chemical compound CCOC(=O)C(C)=C SUPCQIBBMFXVTL-UHFFFAOYSA-N 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 238000002559 palpation Methods 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 229940068984 polyvinyl alcohol Drugs 0.000 description 2
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 2
- 238000002271 resection Methods 0.000 description 2
- 238000004513 sizing Methods 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- LTCQBHPIKOOLGB-UHFFFAOYSA-N 1-hydroxyhexyl 2-methylprop-2-enoate Chemical compound CCCCCC(O)OC(=O)C(C)=C LTCQBHPIKOOLGB-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 229920002943 EPDM rubber Polymers 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 206010021639 Incontinence Diseases 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 206010036976 Prostatism Diseases 0.000 description 1
- 206010051482 Prostatomegaly Diseases 0.000 description 1
- 206010038967 Retrograde ejaculation Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229920002334 Spandex Polymers 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- YVPYQUNUQOZFHG-UHFFFAOYSA-N amidotrizoic acid Chemical compound CC(=O)NC1=C(I)C(NC(C)=O)=C(I)C(C(O)=O)=C1I YVPYQUNUQOZFHG-UHFFFAOYSA-N 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 238000002399 angioplasty Methods 0.000 description 1
- 239000012984 antibiotic solution Substances 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000010894 electron beam technology Methods 0.000 description 1
- 238000002594 fluoroscopy Methods 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 229920001480 hydrophilic copolymer Polymers 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000013208 measuring procedure Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 230000000414 obstructive effect Effects 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 230000036316 preload Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 150000007660 quinolones Chemical class 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 239000012779 reinforcing material Substances 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000004759 spandex Substances 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 238000004381 surface treatment Methods 0.000 description 1
- 238000011477 surgical intervention Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/1075—Balloon catheters with special features or adapted for special applications having a balloon composed of several layers, e.g. by coating or embedding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1018—Balloon inflating or inflation-control devices
- A61M25/10181—Means for forcing inflation fluid into the balloon
- A61M25/10183—Compressible bulbs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1018—Balloon inflating or inflation-control devices
- A61M25/10184—Means for controlling or monitoring inflation or deflation
- A61M25/10185—Valves
- A61M25/10186—One-way valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1018—Balloon inflating or inflation-control devices
- A61M25/10184—Means for controlling or monitoring inflation or deflation
- A61M25/10187—Indicators for the level of inflation or deflation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M29/00—Dilators with or without means for introducing media, e.g. remedies
- A61M29/02—Dilators made of swellable material
Definitions
- This invention relates to medical tissue expansion, and more particularly it pertains to a prostatic tissue expander balloon catheter for expanding the prostatic urethra over a period of time. Inflation balloon pressure is maintained by valves in the inflation lumens. The tissue expander catheter is used to expand the prostatic urethra for the treatment of BPH (Benign Prostatic Hypertrophy).
- BPH Breast Prostatic Hypertrophy
- the sheath enclosed catheter of the dilator is inserted into the urethra.
- the balloons are moved out of the sheath and into working position with the locating balloon in the bulbous urethra, resting against the external sphincter. Positioning is accomplished by palpation, fluoroscopy or by placing a rod lens along side of the PTFE sheath and looking through the transparent locating balloon to confirm diat the dilation balloon is in the proper location.
- the dilation balloon is inflated up to 60 PSI for 10 to 15 minutes, after which both balloons are deflated. The catheter is then drawn back into the sheath and removed.
- Another known device is the Dowd catheter manufactured by Mic ovasive, Inc., which also has a non-distensible dilation balloon measuring 30mm in diameter and 85mm in length.
- a palpation nodule is mounted proximal of the balloon near the proximal end of the shaft.
- a knob is affixed to the shaft to provide a means of maintaining the position of the balloon during inflation.
- the Dowd catheter is manually inserted without benefit of introducers or otiier sheaths. Throughout the entire procedure, the physician has a finger in the rectum against the nodule to judge positioning of the catheter.
- the balloon is inflated up to 60 PSI for the duration of the 10 to 15 minute procedure. During this time d e urologist must maintain traction of the shaft to prevent the balloon from migrating into the bladder. The balloon is removed following deflation by twisting and pulling.
- Distensible balloons as suggested for use in this invention increase in size in proportion to the inflation pressure and shrink or constrict approximately to their original shape upon deflation; non-distensible balloons as used in the prior art are of fixed surface area (the envelope does not readily shrink on deflation) and can cause trauma upon removal.
- Figure 2c is a cross-sectional view of the 2b valve taken along line 2c-2c in Figure 2b
- Figure 3 illustrates a cross-sectional view of the catheter shaft taken along line 3-3 of Figure 1 ;
- Figure 11 shows a syringe with pressure indicator for use with the pump of Figure 9.
- the preferred prostatic tissue expander of this invention as illustrated in Figure 1 includes two inflatable balloons: A first positioning balloon, preferably a Foley balloon, located at the distal tip and a second balloon, a distensible tissue expansion balloon, located proximal of the first balloon.
- a first positioning balloon preferably a Foley balloon, located at the distal tip and a second balloon
- a distensible tissue expansion balloon located proximal of the first balloon.
- the tissue expansion balloon will be available in a range of lengths and sizes for each patient. Being distensible, the diameter of the tissue expansion balloon increases as internal pressure is raised by inflation.
- the catheter shaft upon which the balloons are mounted is of a flexible material and may be reinforced in the region of the tissue expansion balloon to prevent occlusion of the catheter lumens, if required.
- the catheter shaft of this embodiment is equipped with two lumens to connect the balloons to pressure retaining valves located at the proximal end of the device.
- a center lumen is also provided having a proximal connector to attach to a urine collection device, such as a leg bag.
- Insertion of the device into the urethra is similar to the procedure used with a standard Foley catheter: The shaft is lubricated and manually inserted until the distal tip is in the bladder. The positioning balloon is inflated and mild traction is appli d while the tissue expansion balloon is partially inflated. With both balloons inflated, the device is anchored in place. Since no part of the second balloon is in the bladder, there is no tendency of the device to migrate into the bladder. Inflation of the second balloon may be increased gradually over a period of days or weeks to effect tissue expansion. After the expansion reaches a desired level, the balloon may be left in place while the prostate adjusts to the increased size of the urethra and establishes tissue stability. Upon completion of the treatment, the balloons are deflated and returned to their original diameter, approximately that of the device shaft. The device is then withdrawn from the urethra.
- An inflation syringe generally indicated at 32 may be used to inflate the Foley balloon 16 as shown and the distensible tissue expander balloon 18 by connection to the proper inflation port 22 as shown or 26 by means of, for example, Luer fittings. Such fittings are well known in the art.
- Proximal end 21 includes a branched body 34 having a central urine drainage lumen 36 flanked by lumens 38 and 40, all of which extend longitudinally through the catheter shaft 12 of Figure 1.
- Urine drainage lumen 36 is a requisite feature of the device since the device is in place over a period of time extending from days to weeks and provision must be made for urination during that extended time.
- Valvcs 24 and 28 are shown in a preferred construction in Figures 2b and 2a, respectively and in 2c.
- Valve 24 is shown with a standard tapered Leur fitting by means of which the syringe pump of Figure 1 is attached to port 22, as is known in the art. Because the attachment is of relatively short duration, this arrangement is considered to be satisfactory although not critical.
- valve 28 includes a hub fitting 29, another standard Leur fitting known in the art, because a pump ( as will be described further hereinbelow) is attached to port 26 for long term association with the device.
- the two valves 24 and 28 are essentially identical and include the same elements, all of which are preferably formed of any suitable thermoplastic. Many specific materials will be readily apparent to those familiar with the medical device art, including materials other than thermoplastics.
- Both valves include valve bodies 31, a retainer 33 which holds the valve body in place as shown in the respective branch of body 34.
- Valve bodies 31 respectively define the inflation ports 22 or 26 and contain a flexible multi-fingered valve actuator retainer 35 and valve actuator rod 43.
- Actuator rod 43 seats against seat 45 to normally close the valve and is held in place normally by actuator retainer 35 as shown.
- Figure 3 illustrates in cross-sectional view the lumened catheter shaft 12 taken along line 3-3 of Figure 1 where all numerals correspond to those elements previously described. Illustrated in particular are the inflation lumens 38 and 40 flanking the central urine drainage lumen 36. The inflated distensible tissue expander balloon 18 and the positioning balloon 16 at the distal end 14 of the prostatic tissue expander 10 is illustrated in Figure 4 where all numerals correspond to those elements previously described.
- FIG. 5 the cross-section is taken longitudinally and parallel to line 5-5 of Figure 1 in which the positioning balloon 16 and the distensible tissue expander balloon 18 are slightly expanded and in which all numerals correspond to those elements previously described.
- Figure 6 the cross-section is taken along line 6-6 in Figure 5 of the partially inflated - 10- distcnsiblc tissue expander balloon 18 of Figure 5 in which all numerals correspond to those elements previously described.
- Figure 7 the cross-section is taken along line 7-7 of the partially inflated Foley balloon 16 of Figure 5 where all numerals correspond to those elements previously described.
- Illustrated in particular is a reinforcement tube 50 located in the urine lumen 36.
- the positioning balloon 16 (preferably the Foley type) and distensible tissue expander balloon 18 arc shown bonded to or otherwise suitably secured around and about the lumened catheter shaft 12 in communication with their respective balloon ports 44 and 48.
- Inflation lumen 38 is ported to the interior 42 of the positioning balloon 16 by port 44.
- Inflation lumen 40 is ported to the interior 46 of the distensible tissue expander balloon 18 by port 48.
- Optional reinforcement tubes 50 and 52 having interior lumen passageways 50a and 52a respectively, are located and suitably secured in the urine lumen 36 within the Foley balloon 16 and the distensible tissue expander balloon 18, respectively. These may be of a higher modulus elastomer, a thermoplastic or metal.
- a locating nodule 62 as earlier referred to may be included on catheter shaft 12 as shown in Figure 5 and as is known in the art.
- one basic embodiment of the invention comprises the following elements:
- the proximal end of the catheter shaft 12 terminates at the urine drainage funnel end portion 37 and the branched funnels 39 and 41 connected to the minor catheter lumens 38 and 40.
- the urine drainage funnel 37 is preferably the central funnel end portion because it connects to the major lumen 36.
- the funnel length is about 25-60 mm long and is preferably cylindrical, conical or a combination thereof.
- An appropriate connector joins the drainage funnel to a urine collection device (not shown).
- the material used for the funnel is preferably the same as the catheter shaft.
- Inflation funnels 39 and 41 and valves 24 and 28 for positioning and expander balloons 16 and 18 The branched funnels 39 and 41 , preferably cylindrical, 1 are used to connect the minor lumens 38 and 40 to the inflation valves 24 and 28.
- the tissue expander device may include a hydrophilic surface which is bonded to the catheter shaft and balloons.
- a prophylactic antibiotic may be inco ⁇ orated in the hydrophilic surface.
- the antibiotic may be applied by the physician who would soak the expander in an antibiotic solution before placing it in the patient.
- hydrophilic (Hydrogel) materials are listed:
- PV ⁇ Poly Vinyl Alcohol
- Hydrophilic Copolymers are:
- Copolymerization of hydrogels affords the opportunity to tailor the properties such as water content, processing characteristics, and physical properties in die unhydrated state.
- the time release characteristics for the release of antibiotics may also be tailored with copolymerization of the hydrogel surface component.
- the following are examples of antibiotics which have obtained acceptance in the treatment of urinary tract infections, which may be incorporated into a hydrophilic surface:
- the physician can determine if the nodule 62 is at the apex of the prostate, which indicates correct sizing of the expander. While maintaining gentle traction on the positioning balloon, the expander balloon 18 is inflated. To fill the expander the physician uses a syringe with sterile fluid and engages it to the Luer fitting on the check valve 28 for the expander balloon. The syringe is equipped with a pressure gauge to indicate the intraluminal pressure of the expander balloon. Fluid should be introduced into the expander and withdrawn several times, with the external sphincter positioned superior to the prostate, to evacuate any air. The physician then inflates the expander to recommended pressure; checks the fit of the expander after inflation by palpating the locating nodule 62; and disengages the syringe which closes the expander balloon check valve
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Animal Behavior & Ethology (AREA)
- Pulmonology (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Child & Adolescent Psychology (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Media Introduction/Drainage Providing Device (AREA)
- Surgical Instruments (AREA)
- External Artificial Organs (AREA)
Abstract
Priority Applications (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA002246434A CA2246434A1 (fr) | 1996-02-12 | 1996-02-12 | Dispositif d'expansion de tissus prostatiques |
PCT/US1996/002500 WO1997028840A1 (fr) | 1996-02-12 | 1996-02-12 | Dispositif d'expansion de tissus prostatiques |
EP96908513A EP0883417A1 (fr) | 1996-02-12 | 1996-02-12 | Dispositif d'expansion de tissus prostatiques |
JP09528472A JP2001500023A (ja) | 1996-02-12 | 1996-02-12 | 前立腺組織イクスパンダー |
AU51732/96A AU5173296A (en) | 1996-02-12 | 1996-02-12 | Prostatic tissue expander |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1996/002500 WO1997028840A1 (fr) | 1996-02-12 | 1996-02-12 | Dispositif d'expansion de tissus prostatiques |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1997028840A1 true WO1997028840A1 (fr) | 1997-08-14 |
Family
ID=22254760
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1996/002500 WO1997028840A1 (fr) | 1996-02-12 | 1996-02-12 | Dispositif d'expansion de tissus prostatiques |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP0883417A1 (fr) |
JP (1) | JP2001500023A (fr) |
AU (1) | AU5173296A (fr) |
CA (1) | CA2246434A1 (fr) |
WO (1) | WO1997028840A1 (fr) |
Cited By (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000025848A3 (fr) * | 1998-11-02 | 2000-10-05 | Mentor Corp | Expansion de tissu prostatique |
WO2001089619A1 (fr) * | 2000-05-26 | 2001-11-29 | Wallsten Medical S.A. | Catheter a ballonnet |
WO2001076514A3 (fr) * | 2000-04-05 | 2002-05-02 | Kyphon Inc | Methodes et dispositifs destines au traitement d'os fractures et/ou malades |
US6440127B2 (en) | 1998-02-11 | 2002-08-27 | Cosman Company, Inc. | Method for performing intraurethral radio-frequency urethral enlargement |
JP2002538888A (ja) * | 1999-03-15 | 2002-11-19 | イノベイションズ インコーポレーテッド | 膀胱内バルーン |
US6517534B1 (en) | 1998-02-11 | 2003-02-11 | Cosman Company, Inc. | Peri-urethral ablation |
US6743226B2 (en) | 2001-02-09 | 2004-06-01 | Cosman Company, Inc. | Adjustable trans-urethral radio-frequency ablation |
US6899719B2 (en) | 1994-01-26 | 2005-05-31 | Kyphon Inc. | Systems and methods for treating fractured or diseased bone using expandable bodies |
US7153306B2 (en) | 2000-10-25 | 2006-12-26 | Kyphon Inc. | Systems and methods for reducing fractured bone using a fracture reduction cannula |
US7815649B2 (en) | 2000-04-07 | 2010-10-19 | Kyphon SÀRL | Insertion devices and method of use |
US8092480B2 (en) | 2000-04-07 | 2012-01-10 | Kyphon Sarl | Platform cannula for guiding the expansion of expandable bodies and method of use |
US8425489B2 (en) | 2009-05-08 | 2013-04-23 | Medela Holding Ag | Drainage tube device and coupling unit |
WO2017049823A1 (fr) * | 2015-09-21 | 2017-03-30 | 北京优尼康通医疗科技有限公司 | Cathéter de dilatation de la prostate |
WO2018204782A1 (fr) * | 2017-05-05 | 2018-11-08 | Urotronic, Inc. | Cathéters à ballonnet revêtus de médicament pour lumières corporelles |
US10173039B2 (en) | 2013-11-11 | 2019-01-08 | Yong Chul Ahn | Balloon catheter |
US20190015640A1 (en) * | 2012-10-26 | 2019-01-17 | Urotronic, Inc. | Drug-coated balloon catheters for body lumens |
US20190015639A1 (en) * | 2012-10-26 | 2019-01-17 | Urotronic, Inc. | Drug-coated balloon catheters for body lumens |
US10433928B2 (en) | 2015-03-10 | 2019-10-08 | Allergan Pharmaceuticals Holdings (Ireland) Unlimited Company | Multiple needle injector |
USD865950S1 (en) | 2017-03-24 | 2019-11-05 | Allergan, Inc. | Syringe device |
US10596321B2 (en) | 2016-04-08 | 2020-03-24 | Allergan, Inc. | Aspiration and injection device |
US10668188B2 (en) | 2012-10-26 | 2020-06-02 | Urotronic, Inc. | Drug coated balloon catheters for nonvascular strictures |
US10772755B2 (en) | 2003-09-09 | 2020-09-15 | Convatec Technologies Inc. | Fecal management appliance and method and apparatus for introducing same |
US10792427B2 (en) | 2014-05-13 | 2020-10-06 | Allergan, Inc. | High force injection devices |
US10850076B2 (en) | 2012-10-26 | 2020-12-01 | Urotronic, Inc. | Balloon catheters for body lumens |
US10888640B2 (en) | 2015-04-24 | 2021-01-12 | Urotronic, Inc. | Drug coated balloon catheters for nonvascular strictures |
US10898700B2 (en) | 2012-10-26 | 2021-01-26 | Urotronic, Inc. | Balloon catheters for body lumens |
US11185641B2 (en) | 2014-10-01 | 2021-11-30 | Allergan, Inc. | Devices for injection and dosing |
CN114748768A (zh) * | 2021-09-13 | 2022-07-15 | 王江河 | 一种气囊式扩张导管 |
US11504450B2 (en) | 2012-10-26 | 2022-11-22 | Urotronic, Inc. | Drug-coated balloon catheters for body lumens |
US11684719B2 (en) | 2013-05-23 | 2023-06-27 | Allergan, Inc. | Methods of treatment using a syringe extrusion accessory |
US11730864B2 (en) | 2015-04-24 | 2023-08-22 | Urotronic, Inc. | Drug coated balloon catheters for nonvascular strictures |
WO2024006067A1 (fr) * | 2022-06-28 | 2024-01-04 | Growth Armor, LLC | Dispositifs de dilatation améliorés incorporant des caractéristiques améliorées |
US11938287B2 (en) | 2012-10-26 | 2024-03-26 | Urotronic, Inc. | Drug-coated balloon catheters for body lumens |
US11957853B2 (en) | 2019-02-22 | 2024-04-16 | Urotronic, Inc. | Drug-coated balloon catheters for body lumens |
US11992668B2 (en) | 2008-12-02 | 2024-05-28 | Allergan, Inc. | Injection device |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE60326495D1 (de) | 2003-08-21 | 2009-04-16 | Tsukada Medical Res Co Ltd | Intermittierendes selbsthaltendes harnröhren-katheterset |
GB2448892B (en) | 2007-05-01 | 2009-04-29 | Jotillou Entpr Ltd | Catheter |
KR101481887B1 (ko) * | 2013-03-27 | 2015-01-21 | 전북대학교산학협력단 | 삽입 가이드를 이용하는 카테터 및 카테터 삽입 방법 |
KR101487594B1 (ko) * | 2013-03-27 | 2015-01-29 | 전북대학교산학협력단 | 전립선 치료용 벌룬 카테터 |
KR101610282B1 (ko) * | 2013-11-11 | 2016-04-07 | (주)쓰리에이엠 | 벌룬 카테터 |
KR20150136379A (ko) * | 2014-05-27 | 2015-12-07 | 이제범 | 전립선 고정용 카테타 |
US11160960B2 (en) | 2016-09-19 | 2021-11-02 | Boston Scientific Scimed, Inc. | Anastomotic drainage stent |
WO2018119442A1 (fr) * | 2016-12-22 | 2018-06-28 | Applied Tissue Technologies Llc | Dispositifs et procédés pour le traitement des plaies |
KR102329622B1 (ko) * | 2019-12-18 | 2021-11-22 | 충북대학교 산학협력단 | 와상 환자용 자동 배뇨 장치 |
KR20230002291U (ko) * | 2022-05-25 | 2023-12-04 | 박종윤 | 두개의 풍선을 소유한 요도도뇨관과 요도스텐트용 밀대 |
CN116236676B (zh) * | 2023-02-20 | 2024-07-23 | 中国医学科学院北京协和医院 | 用于泌尿外科腔镜手术的球囊扩展器 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4932958A (en) * | 1988-05-10 | 1990-06-12 | American Medical Systems, Inc. | Prostate balloon dilator |
US5002558A (en) * | 1989-08-23 | 1991-03-26 | The Beth Israel Hospital Association | Adjustable urethral catheter and method for treating obstructive prostatism |
US5007897A (en) * | 1989-05-30 | 1991-04-16 | Kalb Irvin M | Drug delivery catheter |
EP0449472A1 (fr) * | 1990-03-22 | 1991-10-02 | Argomed Ltd | Appareil pour thermothérapie localisée pour les mammifères |
WO1992004934A1 (fr) * | 1990-09-14 | 1992-04-02 | American Medical Systems, Inc. | Catheter d'hyperthermie et de dilatation combines |
WO1992008512A1 (fr) * | 1990-11-09 | 1992-05-29 | Boston Scientific Corporation | Ballonnet pour catheter a usage medical |
-
1996
- 1996-02-12 WO PCT/US1996/002500 patent/WO1997028840A1/fr not_active Application Discontinuation
- 1996-02-12 AU AU51732/96A patent/AU5173296A/en not_active Abandoned
- 1996-02-12 CA CA002246434A patent/CA2246434A1/fr not_active Abandoned
- 1996-02-12 EP EP96908513A patent/EP0883417A1/fr not_active Withdrawn
- 1996-02-12 JP JP09528472A patent/JP2001500023A/ja active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4932958A (en) * | 1988-05-10 | 1990-06-12 | American Medical Systems, Inc. | Prostate balloon dilator |
US5007897A (en) * | 1989-05-30 | 1991-04-16 | Kalb Irvin M | Drug delivery catheter |
US5002558A (en) * | 1989-08-23 | 1991-03-26 | The Beth Israel Hospital Association | Adjustable urethral catheter and method for treating obstructive prostatism |
EP0449472A1 (fr) * | 1990-03-22 | 1991-10-02 | Argomed Ltd | Appareil pour thermothérapie localisée pour les mammifères |
WO1992004934A1 (fr) * | 1990-09-14 | 1992-04-02 | American Medical Systems, Inc. | Catheter d'hyperthermie et de dilatation combines |
WO1992008512A1 (fr) * | 1990-11-09 | 1992-05-29 | Boston Scientific Corporation | Ballonnet pour catheter a usage medical |
Cited By (70)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6899719B2 (en) | 1994-01-26 | 2005-05-31 | Kyphon Inc. | Systems and methods for treating fractured or diseased bone using expandable bodies |
US7959638B2 (en) | 1997-06-09 | 2011-06-14 | Kyphon Sarl | Methods and devices for treating bone after high velocity and/or trauma fracture |
US6517534B1 (en) | 1998-02-11 | 2003-02-11 | Cosman Company, Inc. | Peri-urethral ablation |
US6692493B2 (en) | 1998-02-11 | 2004-02-17 | Cosman Company, Inc. | Method for performing intraurethral radio-frequency urethral enlargement |
US6440127B2 (en) | 1998-02-11 | 2002-08-27 | Cosman Company, Inc. | Method for performing intraurethral radio-frequency urethral enlargement |
US7927339B2 (en) | 1998-08-14 | 2011-04-19 | Kyphon Sarl | Systems and methods for reducing fractured bone using a fracture reduction cannula with a side discharge port |
US6726691B2 (en) | 1998-08-14 | 2004-04-27 | Kyphon Inc. | Methods for treating fractured and/or diseased bone |
US8454620B2 (en) | 1998-08-14 | 2013-06-04 | Kyphon Sarl | Systems and methods for reducing fractured bone using a fracture reduction cannula with a side discharge port |
WO2000025848A3 (fr) * | 1998-11-02 | 2000-10-05 | Mentor Corp | Expansion de tissu prostatique |
JP2002538888A (ja) * | 1999-03-15 | 2002-11-19 | イノベイションズ インコーポレーテッド | 膀胱内バルーン |
KR100717224B1 (ko) * | 2000-04-05 | 2007-05-11 | 키폰 인크. | 골절되거나 병든 뼈를 치료하는 방법 및 장치 |
WO2001076514A3 (fr) * | 2000-04-05 | 2002-05-02 | Kyphon Inc | Methodes et dispositifs destines au traitement d'os fractures et/ou malades |
US7815649B2 (en) | 2000-04-07 | 2010-10-19 | Kyphon SÀRL | Insertion devices and method of use |
US8092480B2 (en) | 2000-04-07 | 2012-01-10 | Kyphon Sarl | Platform cannula for guiding the expansion of expandable bodies and method of use |
US7156860B2 (en) | 2000-05-26 | 2007-01-02 | Wallsten Medical S.A. | Balloon catheter |
JP2003534064A (ja) * | 2000-05-26 | 2003-11-18 | ヴァルステン・メディカル・エス・アー | バルーンカテーテル |
WO2001089619A1 (fr) * | 2000-05-26 | 2001-11-29 | Wallsten Medical S.A. | Catheter a ballonnet |
US7153306B2 (en) | 2000-10-25 | 2006-12-26 | Kyphon Inc. | Systems and methods for reducing fractured bone using a fracture reduction cannula |
US6743226B2 (en) | 2001-02-09 | 2004-06-01 | Cosman Company, Inc. | Adjustable trans-urethral radio-frequency ablation |
US10772755B2 (en) | 2003-09-09 | 2020-09-15 | Convatec Technologies Inc. | Fecal management appliance and method and apparatus for introducing same |
US11992668B2 (en) | 2008-12-02 | 2024-05-28 | Allergan, Inc. | Injection device |
US8425489B2 (en) | 2009-05-08 | 2013-04-23 | Medela Holding Ag | Drainage tube device and coupling unit |
US10675386B2 (en) | 2012-10-26 | 2020-06-09 | Urotronic, Inc. | Drug coated balloon catheters for nonvascular strictures |
US11648337B2 (en) | 2012-10-26 | 2023-05-16 | Urotronic, Inc. | Drug-coated balloon catheters for body lumens |
US20190015639A1 (en) * | 2012-10-26 | 2019-01-17 | Urotronic, Inc. | Drug-coated balloon catheters for body lumens |
US12115286B2 (en) | 2012-10-26 | 2024-10-15 | Urotronic, Inc. | Drug-coated balloon catheters for body lumens |
US12168108B2 (en) | 2012-10-26 | 2024-12-17 | Urotronic, Inc. | Balloon catheters for body lumens |
US11938287B2 (en) | 2012-10-26 | 2024-03-26 | Urotronic, Inc. | Drug-coated balloon catheters for body lumens |
US11925729B2 (en) | 2012-10-26 | 2024-03-12 | Urotronic, Inc. | Drug-coated balloon catheters for body lumens |
US12280179B2 (en) | 2012-10-26 | 2025-04-22 | Urotronic, Inc. | Drug-coated balloon catheters for body lumens |
US11826532B2 (en) | 2012-10-26 | 2023-11-28 | Urotronic, Inc. | Balloon catheters for body lumens |
US11826533B2 (en) | 2012-10-26 | 2023-11-28 | Urotronic, Inc. | Balloon catheters for body lumens |
US10668188B2 (en) | 2012-10-26 | 2020-06-02 | Urotronic, Inc. | Drug coated balloon catheters for nonvascular strictures |
US11648338B2 (en) | 2012-10-26 | 2023-05-16 | Urotronic, Inc. | Drug-coated balloon catheters for body lumens |
US20190015640A1 (en) * | 2012-10-26 | 2019-01-17 | Urotronic, Inc. | Drug-coated balloon catheters for body lumens |
US11471656B2 (en) | 2012-10-26 | 2022-10-18 | Urotronic, Inc. | Drug-coated balloon catheters for body lumens |
US10806830B2 (en) * | 2012-10-26 | 2020-10-20 | Urotronic, Inc. | Drug-coated balloon catheters for body lumens |
US10850076B2 (en) | 2012-10-26 | 2020-12-01 | Urotronic, Inc. | Balloon catheters for body lumens |
US10881839B2 (en) | 2012-10-26 | 2021-01-05 | Urotronic, Inc. | Drug-coated balloon catheters for body lumens |
US11504450B2 (en) | 2012-10-26 | 2022-11-22 | Urotronic, Inc. | Drug-coated balloon catheters for body lumens |
US10898700B2 (en) | 2012-10-26 | 2021-01-26 | Urotronic, Inc. | Balloon catheters for body lumens |
US10987451B2 (en) * | 2012-10-26 | 2021-04-27 | Urotronic, Inc. | Drug-coated balloon catheters for body lumens |
US10994103B2 (en) | 2012-10-26 | 2021-05-04 | Urotronic, Inc. | Drug-coated balloon catheters for body lumens |
US10994104B2 (en) | 2012-10-26 | 2021-05-04 | Urotronic, Inc. | Balloon catheters for body lumens |
US11471655B2 (en) | 2012-10-26 | 2022-10-18 | Urotronic, Inc. | Drug-coated balloon catheters for body lumens |
US12280226B2 (en) | 2012-10-26 | 2025-04-22 | Urotronic, Inc. | Drug-coated balloon catheters for body lumens |
US11439801B2 (en) | 2012-10-26 | 2022-09-13 | Urotronic, Inc. | Balloon catheters for body lumens |
US11684719B2 (en) | 2013-05-23 | 2023-06-27 | Allergan, Inc. | Methods of treatment using a syringe extrusion accessory |
US10173039B2 (en) | 2013-11-11 | 2019-01-08 | Yong Chul Ahn | Balloon catheter |
US10792427B2 (en) | 2014-05-13 | 2020-10-06 | Allergan, Inc. | High force injection devices |
US11185641B2 (en) | 2014-10-01 | 2021-11-30 | Allergan, Inc. | Devices for injection and dosing |
US10433928B2 (en) | 2015-03-10 | 2019-10-08 | Allergan Pharmaceuticals Holdings (Ireland) Unlimited Company | Multiple needle injector |
US11484628B2 (en) | 2015-04-24 | 2022-11-01 | Urotronic, Inc. | Drug coated balloon catheters for nonvascular strictures |
US10888640B2 (en) | 2015-04-24 | 2021-01-12 | Urotronic, Inc. | Drug coated balloon catheters for nonvascular strictures |
US12102737B2 (en) | 2015-04-24 | 2024-10-01 | Urotronic, Inc. | Drug coated balloon catheters for nonvascular strictures |
US11730864B2 (en) | 2015-04-24 | 2023-08-22 | Urotronic, Inc. | Drug coated balloon catheters for nonvascular strictures |
US11904072B2 (en) | 2015-04-24 | 2024-02-20 | Urotronic, Inc. | Drug coated balloon catheters for nonvascular strictures |
WO2017049823A1 (fr) * | 2015-09-21 | 2017-03-30 | 北京优尼康通医疗科技有限公司 | Cathéter de dilatation de la prostate |
US10596321B2 (en) | 2016-04-08 | 2020-03-24 | Allergan, Inc. | Aspiration and injection device |
US11890457B2 (en) | 2016-04-08 | 2024-02-06 | Allergan, Inc. | Aspiration and injection device |
USD867582S1 (en) | 2017-03-24 | 2019-11-19 | Allergan, Inc. | Syringe device |
USD865949S1 (en) | 2017-03-24 | 2019-11-05 | Allergan, Inc. | Syringe device |
USD865950S1 (en) | 2017-03-24 | 2019-11-05 | Allergan, Inc. | Syringe device |
USD865948S1 (en) | 2017-03-24 | 2019-11-05 | Allergan, Inc. | Syringe device |
USD866753S1 (en) | 2017-03-24 | 2019-11-12 | Allergan, Inc. | Syringe device |
WO2018204782A1 (fr) * | 2017-05-05 | 2018-11-08 | Urotronic, Inc. | Cathéters à ballonnet revêtus de médicament pour lumières corporelles |
US12005206B2 (en) | 2019-02-22 | 2024-06-11 | Urotronic, Inc. | Drug-coated balloon catheters for body lumens |
US11957853B2 (en) | 2019-02-22 | 2024-04-16 | Urotronic, Inc. | Drug-coated balloon catheters for body lumens |
CN114748768A (zh) * | 2021-09-13 | 2022-07-15 | 王江河 | 一种气囊式扩张导管 |
WO2024006067A1 (fr) * | 2022-06-28 | 2024-01-04 | Growth Armor, LLC | Dispositifs de dilatation améliorés incorporant des caractéristiques améliorées |
Also Published As
Publication number | Publication date |
---|---|
EP0883417A1 (fr) | 1998-12-16 |
CA2246434A1 (fr) | 1997-08-14 |
JP2001500023A (ja) | 2001-01-09 |
AU5173296A (en) | 1997-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6102929A (en) | Prostatic tissue expander | |
WO1997028840A1 (fr) | Dispositif d'expansion de tissus prostatiques | |
EP0417189B1 (fr) | Catheter de dilatation par ballon | |
EP0813434B1 (fr) | Dispositif a dilatation lente pour l'uretre | |
US6045498A (en) | Method for adjustably restricting a body lumen | |
US5090424A (en) | Conformable urethral plug | |
CA1330187C (fr) | Catheter de dilatation a ballonnet | |
US5312430A (en) | Balloon dilation catheter | |
US5527336A (en) | Flow obstruction treatment method | |
AU613247B2 (en) | Prostate balloon dilator | |
US6364868B1 (en) | Ureteral catheter and tissue expander and method of megaureter creation | |
US4893623A (en) | Method and apparatus for treating hypertrophy of the prostate gland | |
US7828716B2 (en) | Implantable device and method for adjustably restricting a body lumen | |
US6013102A (en) | Device for maintaining urinary continence | |
US4762128A (en) | Method and apparatus for treating hypertrophy of the prostate gland | |
US5314443A (en) | Prostate balloon dilatation catheter | |
US4705502A (en) | Suprapubic catheter with dual balloons | |
CA1326199C (fr) | Sonde a ballonnet pour la dilatation de l'uretre prostatique | |
ES2252981T3 (es) | Dispositivo de suspension distensible para incontinencia urinaria. | |
CA1163754A (fr) | Systeme implantable pour provoquer l'erection du penis | |
CA2592857A1 (fr) | Valve regulatrice de pression de l'uretre servant a maitriser l'incontinence | |
EP0421031B1 (fr) | Dilatateur prostatique à ballon | |
GB2245499A (en) | Catheters. | |
Robinson | Selecting a urinary catheter and drainage system | |
NO175886B (no) | Apparat for utvidelse av prostata urethra |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AM AT AU BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU JP KE KG KP KR KZ LK LR LT LU LV MD MG MN MW MX NO NZ PL PT RO RU SD SE SI SK TJ TT UA UZ VN |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
ENP | Entry into the national phase |
Ref document number: 2246434 Country of ref document: CA Ref country code: JP Ref document number: 1997 528472 Kind code of ref document: A Format of ref document f/p: F Ref country code: CA Ref document number: 2246434 Kind code of ref document: A Format of ref document f/p: F |
|
NENP | Non-entry into the national phase |
Ref country code: JP Ref document number: 97528472 Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1996908513 Country of ref document: EP |
|
122 | Ep: pct application non-entry in european phase | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
122 | Ep: pct application non-entry in european phase | ||
WWP | Wipo information: published in national office |
Ref document number: 1996908513 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1996908513 Country of ref document: EP |